Patent · US Active

Compounds having muscarinic receptor antagonist and beta2 Adrenergic receptor agonist activity

US8877774B2 · kind B2 · utility

2Cited by

0References

21Claims

0Family size

Assignee

Chiesi Farmaceutici S.p.A. · IT

Inventors

Fabio Rancati · Parma, IT
Andrea Rizzi · Parma, IT
Gabriele Amari · Parma, IT
Matteo Biagetti · Verona, IT
Ian Linney · London, GB

Key dates

Filing date	Jun 8, 2012
Grant date	Nov 4, 2014
Priority date	—
Expiry date	Aug 11, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D221/22
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compounds of formula(I) act both as muscarinic receptor antagonists and beta2 adrenergic receptor agonists and are useful for the prevention and/or treatment of broncho-obstructive and inflammatory diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.